Table 1.
Cell line | Tumor origin | Gender | Source | References* |
TPC-1 | Papillary carcinoma | Female | Prof Dumont JE; Prof Mareel M; Laboratory of Experimental Cancerology, Ghent University Hospital, Ghent, Belgium |
Tanaka et al. 1987 [10] Jossart et al. 1995 [15] Miura et al. 2003 [20] van Staveren et al. 2007 [21] |
FB2 (TPC-1) |
Papillary carcinoma | Female | Prof. Santoro M; Centro di Endocrinologia ed Oncologia Sperimentale, Napoly, Italy |
Basolo et al. 2002 [16] |
K1 (GLAG-66) |
Papillary carcinoma | Male | Prof. Wynford-Thomas D; Department of Pathology, University of Wales College of Medicine, Cardiff, U.K. |
Antonini et al. 1993 [19] Challeton et al. 1997 [18] |
B-CPAP | Papillary carcinoma | Female | Prof Mareel M; Laboratory of Experimental Cancerology, Ghent University Hospital, Ghent, Belgium |
Paulin et al. 1992 [29] Corso et al. 2002 [22] Dettori et al. 2004 [23] van Staveren et al. 2007 [21] |
XTC-1 | Follicular carcinoma (Hürthle cell) | Female | Prof. Savagner F; Laboratoire de Biochimie et Biologie Moleculaire, Faculte de Medecine, Angers, France |
Zielke et al. 1998 [30] |
HTH74 | Undifferentiated carcinoma | Female | Prof Mareel M; Laboratory of Experimental Cancerology, Ghent University Hospital, Ghent, Belgium |
Heldin et al. 1991 [31] Lee et al. 2007 [24] |
C643 | Undifferentiated carcinoma | Male | Prof Mareel M; Laboratory of Experimental Cancerology, Ghent University Hospital, Ghent, Belgium |
Mark et al. 1987 [32] Lee et al. 2007 [24] |
8505C | Undifferentiated carcinoma | Female | Prof Mareel M; Laboratory of Experimental Cancerology, Ghent University Hospital, Ghent, Belgium |
Ito et al. 1992 [33] van Staveren et al. 2007 [21] Lee et al. 2007 [24] |
* Only papers detailing the establishment (references in bold) or providing relevant genetic information for each cell line are indicated.